PHOENIX NEW MED.ADR 1/48 Working Capital to Net Assets Ratio
PHOENIX NEW MED.ADR 1/48 working capital to net assets ratio. PHOENIX NEW MED.ADR 1/48 (1PX) has a Working Capital to Net Assets ratio of 83.0% as of December 2025. Working capital of €920.04 Million (current assets of €1.42 Billion minus current liabilities of €498.25 Million) is measured against net assets of €1.11 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. Check tangible equity quality of PHOENIX NEW MED.ADR 1/48 to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of PHOENIX NEW MED.ADR 1/48 (2021–2025)
Working capital to net assets ratio of PHOENIX NEW MED.ADR 1/48 from 2021 to 2025. This chart shows how PHOENIX NEW MED.ADR 1/48's Working Capital to Net Assets ratio has evolved across 5 annual periods from 2021 to 2025. As of December 2025, the ratio stands at 83.0%, reflecting working capital of €920.04 Million against net assets of €1.11 Billion EUR. See PHOENIX NEW MED.ADR 1/48 defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.
PHOENIX NEW MED.ADR 1/48 Working Capital to Net Assets Ratio by Year (2021–2025)
PHOENIX NEW MED.ADR 1/48 working capital to net assets ratio by year from 2021 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for PHOENIX NEW MED.ADR 1/48 from 2021 to 2025, covering 5 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see 1PX asset base.
| Year | WC/NA Ratio | Working Capital (EUR) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 83.0% | €920.04 Million | €1.11 Billion | €1.42 Billion | €498.25 Million | ▼ -1.1 pp |
| 2024 | 84.2% | €937.03 Million | €1.11 Billion | €1.47 Billion | €537.32 Million | ▲ +2.4 pp |
| 2023 | 81.8% | €951.63 Million | €1.16 Billion | €1.48 Billion | €526.99 Million | ▲ +3.0 pp |
| 2022 | 78.8% | €997.33 Million | €1.27 Billion | €1.66 Billion | €664.32 Million | ▼ -1.1 pp |
| 2021 | 79.9% | €1.11 Billion | €1.39 Billion | €2.08 Billion | €966.98 Million | — |